Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
about
Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Validation of histone deacetyl ...... ion-resistant prostate cancer.
@en
Validation of histone deacetyl ...... ion-resistant prostate cancer.
@nl
type
label
Validation of histone deacetyl ...... ion-resistant prostate cancer.
@en
Validation of histone deacetyl ...... ion-resistant prostate cancer.
@nl
prefLabel
Validation of histone deacetyl ...... ion-resistant prostate cancer.
@en
Validation of histone deacetyl ...... ion-resistant prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Validation of histone deacetyl ...... tion-resistant prostate cancer
@en
P2093
Abigail B McLeod
Ching-Yi Chang
Holly M Alley
James P Stice
Suzanne E Wardell
P2860
P304
P356
10.1002/PROS.23467
P577
2017-12-15T00:00:00Z